Topotecan enhances immune clearance of gliomas

INIS

• ligands 100%
• gliomas 100%
• tumors 66%
• glioblastomas 50%
• patients 33%
• therapy 33%
• tumor cells 33%
• brain 33%
• additives 33%
• receptors 33%
• immunotherapy 33%
• apoptosis 33%
• chemotherapy 33%
• clearance 33%
• mice 16%
• data 16%
• animals 16%
• humans 16%
• drugs 16%
• surgery 16%
• interactions 16%
• administration 16%
• regulations 16%
• cytokines 16%
• inhibition 16%
• toxicity 16%
• refractories 16%
• antibodies 16%
• modulation 16%
• radiotherapy 16%
• survival time 16%
• cell killing 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Glioma 100%
• Fas Ligand 100%
• Neoplasm 83%
• Glioblastoma 50%
• Topotecan 50%
• Immunotherapy 33%
• Chemotherapy 33%
• Tumor Necrosis Factor Receptor Superfamily Member 6 33%
• Cell Death 33%
• Cytotoxicity 16%
• Antibody 16%
• Enalapril Maleate 16%
• Cytokine 16%
• Cytotoxic Agent 16%
• Temozolomide 16%
• Median Survival Time 16%
• Brain Tumor 16%
• Animal 16%
• Drug 16%
• Mouse 16%
• Radiation 16%

Neuroscience

• Glioma 100%
• Fas Ligand 100%
• Glioblastoma Multiforme 50%
• Topotecan 50%
• Immunotherapy 33%
• Chemotherapy 33%
• Fas Receptor 33%
• Cell Line 16%
• Cytotoxicity 16%
• Antibodies 16%
• Brain Tumor 16%
• Radiation Therapy 16%
• Cytokine 16%
• Temozolomide 16%
• Cell Killing 16%
• Brain 16%